Clinical Trial Update: A Study of the Safety and Antiretroviral Activity of 3BNC117 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and antiretroviral activity of 3BNC117 in HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 3BNC117

Snippet

Sponsor: Rockefeller University | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-06-16